News & Updates

Show Multimedia Only

Ultraprocessed foods are the new cigarettes: study

17 Feb 2026 by

Ultraprocessed foods (UPFs) are associated with several preventable diseases and must be viewed not only through a nutritional lens but also as addictive, industrially engineered substances, which can be likened to cigarettes, suggests a recent study.

Ultraprocessed foods are the new cigarettes: study

17 Feb 2026

Is immediate better than delayed angiography after cardiac arrest?

17 Feb 2026

Five-year survival does not significantly differ between immediate and delayed coronary angiography in patients resuscitated from out-of-hospital cardiac arrest (OHCA) without ST-segment elevation, reports a recent study.

Is immediate better than delayed angiography after cardiac arrest?

17 Feb 2026

Metformin disappoints in peripheral artery disease

17 Feb 2026

Treatment with metformin does not appear to improve the walking ability of patients with peripheral artery disease (PAD) but no diabetes, according to a study.

Metformin disappoints in peripheral artery disease

17 Feb 2026

Upadacitinib stays effective for 1 year in real-world UC patients

16 Feb 2026 by

Treatment with upadacitinib appears to yield high and durable remission rates in patients with ulcerative colitis (UC), according to 1-year data from a real-world study.

Upadacitinib stays effective for 1 year in real-world UC patients

16 Feb 2026

Some therapies for psoriasis, PSA linked to HBV, HCV reactivation

16 Feb 2026

A 15-year study recommends taking into consideration the differential risks of hepatitis B virus (HBV) and hepatitis C virus (HCV) reactivations when choosing targeted therapies for the treatment of psoriasis and psoriatic arthritis (PsA), particularly in patients with risk factors for viral reactivation.

Some therapies for psoriasis, PSA linked to HBV, HCV reactivation

16 Feb 2026

GLP-1 RAs may lower long-term mortality risk in AIS patients

16 Feb 2026 by

The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) appears to contribute to a long-term reduced risk of death in patients with acute ischaemic stroke (AIS), suggests a study. However, less than 1 percent of these individuals have been prescribed GLP-1 RAs upon discharge.

GLP-1 RAs may lower long-term mortality risk in AIS patients

16 Feb 2026

Faster sodium correction prevents 90-day death, neurologic events in hyponatremia patients

16 Feb 2026

Faster sodium correction results in a reduced risk for 90-day death or delayed neurologic events among patients with severe hyponatremia, reveals a study.

Faster sodium correction prevents 90-day death, neurologic events in hyponatremia patients

16 Feb 2026

Abelacimab provides greater protection against bleeding in older AF patients

16 Feb 2026

Abelacimab consistently reduces the risk of bleeding in patients with atrial fibrillation (AF) regardless of age, with the risk reduction seemingly greater for those with older age, according to the phase IIb AZALEA-TIMI 71 trial.

Abelacimab provides greater protection against bleeding in older AF patients

16 Feb 2026

GLP-1 RAs bring a number of benefits in IBD

15 Feb 2026 by

The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) among patients with inflammatory bowel disease (IBD) appears to result in favourable clinical outcomes, as shown in two retrospective studies.

GLP-1 RAs bring a number of benefits in IBD

15 Feb 2026

Haemoglobin concentration in early pregnancy predicts neonatal morbidity, mortality

15 Feb 2026

Anaemia and relative erythrocytosis during early pregnancy are independently associated with neonatal morbidity and mortality, a study has found.

Haemoglobin concentration in early pregnancy predicts neonatal morbidity, mortality

15 Feb 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Ultraprocessed foods are the new cigarettes: study

Ultraprocessed foods are the new cigarettes: study

Is immediate better than delayed angiography after cardiac arrest?

Is immediate better than delayed angiography after cardiac arrest?

Metformin disappoints in peripheral artery disease

Metformin disappoints in peripheral artery disease

Upadacitinib stays effective for 1 year in real-world UC patients

Upadacitinib stays effective for 1 year in real-world UC patients

Some therapies for psoriasis, PSA linked to HBV, HCV reactivation

Some therapies for psoriasis, PSA linked to HBV, HCV reactivation

GLP-1 RAs may lower long-term mortality risk in AIS patients

GLP-1 RAs may lower long-term mortality risk in AIS patients

Faster sodium correction prevents 90-day death, neurologic events in hyponatremia patients

Faster sodium correction prevents 90-day death, neurologic events in hyponatremia patients

Abelacimab provides greater protection against bleeding in older AF patients

Abelacimab provides greater protection against bleeding in older AF patients

GLP-1 RAs bring a number of benefits in IBD

GLP-1 RAs bring a number of benefits in IBD

Haemoglobin concentration in early pregnancy predicts neonatal morbidity, mortality

Haemoglobin concentration in early pregnancy predicts neonatal morbidity, mortality